Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia

Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia

Aim. To evaluate the clinical experience of bosutinib use for treatment of chronic myeloid leukemia (CML) patients with intolerance and resistance to other tyrosine kinase inhibitors (TKI), as well as to compare the obtained results with the data of clinical trials. Materials & Methods. The a...

Full description

Bibliographic Details
Main Authors: VA Shuvaev, OYu Vinogradova, IS Martynkevich, NV Novitskaya, MS Fominykh, SN Tsareva, DI Shikhbabaeva, MM Pankrashkina, MV Chernikov, NN Sharkunov, II Zotova, VYu Udal’eva, EV Motyko, SV Voloshin,5,6
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2018-10-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
chronic myeloid leukemia
bosutinib
target therapy
tyrosine kinase inhibitors
clinical practice
Online Access:http://bloodjournal.ru/wp-content/uploads/2018/09/2-1.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2018/09/2-1.pdf

Similar Items